On June 6, Docusign reported results for its fiscal 2026 first quarter (which ended April 30), and management increased its full-year revenue guidance, which signals clear momentum across the business ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Shares of DocuSign tanked 18% in trading on Friday, a day after the e-signature provider reported stronger-than-expected ...

Nathan added that estimates for Broadcom's ( AVGO) third quarter revenue have been falling slightly over the last month and ...

DocuSign (DOCU) stocks are available ... are typically considered safer than investing in a single stock, because their values fluctuate at different times and their peaks and troughs can balance ...

Cheng Xin / Getty Images Docusign shares jumped nearly 20% Friday after the technology company reported better-than-expected fourth-quarter earnings. CEO Allan Thygesen said the company is seeing ...

DocuSign (NASDAQ: DOCU) stock surged 15.4% through 10:30 a.m. ET Friday after reporting a modest earnings beat last night. Heading into the fiscal fourth quarter 2025 report, analysts forecast ...

DocuSign (DOCU +23%) is surging today following its Q3 (Oct ... and early success of its Intelligent Agreement Management (IAM) platform is driving the stock today. In terms of the key operating ...

DocuSign stock climbed after Wall Street analysts raise price targets following upbeat quarterly print. Analysts laud DocuSign's revenue, billings growth, IAM while they await durable signs of ...

Operator Greetings, and welcome to the DocuSign Q3 fiscal 2025 earnings call ... together with the content of this call. *Stock Advisor returns as of December 2, 2024 This article is a transcript ...